Exploring the Latest Research and Manufacturing Challenges in T-reg Therapy
In this presentation, Dr. Qizhi Tang, Professor and Director at the Transplantation Research Lab in the Department of Surgery at the University of California, San Francisco discusses the latest developments in T-reg research and clinical application.
The Tang lab focuses on translating knowledge on mechanisms of immune tolerance into novel therapeutics for treating autoimmune disease, diabetes and preventing transplant rejection. Currently, two major areas of her work are focused on the therapeutic application of regulatory T cell therapy in type 1 diabetes and transplant rejection, or GvHD.
In this presentation, she shares the latest research conducted by her lab using T-reg cells for therapy, the benefits of these therapies, and explores the technical challenge of commercializing T-reg therapies that require new approaches in manufacturing and regulatory review.